Palisade Bio (PALI) Payables (2010 - 2026)
Palisade Bio (PALI) posted Payables of $1.84 million for Q2 2026, up 33.6% from $1.37 million a year earlier but down 31.9% from the prior quarter.
Analysis
Palisade Bio (PALI) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Palisade Bio's Payables came in at $767,000, down 30.6% from FY2024.
- Annual Payables shows a five-year compound annual growth rate of -21.3% (FY2020 to FY2025).
- In prior years, Palisade Bio's Payables was $1.11 million in FY2024 (+58.3%), $698,000 in FY2023 (-60.3%), $1.76 million in FY2022 (+33.0%) and $1.32 million in FY2021 (-47.9%).
- Quarterly Payables has run from a low of $366,000 in Q3 2024 to a high of $2.7 million in Q1 2026 over five years.
- On a year-over-year basis, Payables increased in six of the last eight quarters, with growth averaging 97.6%.
- The strongest year-over-year quarter for Payables in the past five years was Q3 2025, with growth of 289.6%; the weakest was Q3 2024, with a decline of 61.5%.
- According to Business Quant data, Payables for the three prior quarters was $2.7 million (Q1 2026), $767,000 (Q4 2025) and $1.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Palisade Bio | 249.43 Mn | -147.01 Mn | - | 1.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.84 Mn |
| Mar 31, 2026 | 2.70 Mn |
| Dec 31, 2025 | 767,000.00 |
| Sep 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 745,000.00 |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 366,000.00 |
| Jun 30, 2024 | 514,000.00 |
| Mar 31, 2024 | 459,000.00 |
| Dec 31, 2023 | 698,000.00 |
| Sep 30, 2023 | 950,000.00 |
| Jun 30, 2023 | 922,000.00 |
| Mar 31, 2023 | 706,000.00 |
| Dec 31, 2022 | 1.76 Mn |
| Sep 30, 2022 | 1.73 Mn |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | 1.32 Mn |
| Sep 30, 2021 | 1.38 Mn |
API Access
Palisade Bio Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=PALI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "PALI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=PALI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();